The AMIGAL brand, founded in 2005 (United States), from 7 sister brands and 2214 competing brands. The AMIGAL brand is owned by Amicus Therapeutics, a company listed in New York. AMIGAL belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Amicus Therapeutics
(AMIGAL)
over 5 years*
USD 10.13